位置:首页 > 蛋白库 > POL_RSVSB
POL_RSVSB
ID   POL_RSVSB               Reviewed;        1603 AA.
AC   O92956;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 2.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=Gag-Pol polyprotein;
DE   Contains:
DE     RecName: Full=Matrix protein p19;
DE   Contains:
DE     RecName: Full=p2A;
DE   Contains:
DE     RecName: Full=p2B;
DE   Contains:
DE     RecName: Full=p10;
DE   Contains:
DE     RecName: Full=Capsid protein p27, alternate cleaved 1;
DE   Contains:
DE     RecName: Full=Capsid protein p27, alternate cleaved 2;
DE   Contains:
DE     RecName: Full=p3;
DE   Contains:
DE     RecName: Full=Nucleocapsid protein p12;
DE   Contains:
DE     RecName: Full=Protease p15;
DE              EC=3.4.23.- {ECO:0000255|PROSITE-ProRule:PRU00275};
DE   Contains:
DE     RecName: Full=Reverse transcriptase beta-subunit;
DE              Short=RT-beta;
DE   Contains:
DE     RecName: Full=Reverse transcriptase alpha-subunit;
DE              Short=RT-alpha;
DE              EC=2.7.7.49 {ECO:0000255|PROSITE-ProRule:PRU00405};
DE              EC=2.7.7.7 {ECO:0000255|PROSITE-ProRule:PRU00405};
DE              EC=3.1.26.4 {ECO:0000255|PROSITE-ProRule:PRU00408};
DE   Contains:
DE     RecName: Full=Integrase;
DE              Short=IN;
DE              EC=2.7.7.- {ECO:0000269|PubMed:9218451};
DE              EC=3.1.-.- {ECO:0000269|PubMed:9218451};
DE     AltName: Full=pp32;
DE   Contains:
DE     RecName: Full=p4;
GN   Name=gag-pol;
OS   Rous sarcoma virus (strain Schmidt-Ruppin B) (RSV-SRB).
OC   Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes;
OC   Ortervirales; Retroviridae; Orthoretrovirinae; Alpharetrovirus.
OX   NCBI_TaxID=269447;
OH   NCBI_TaxID=9031; Gallus gallus (Chicken).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Bouck J., Skalka A.M., Katz R.A.;
RT   "Complete nucleotide sequence of avian sarcoma virus.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   REVIEW (INTEGRASE).
RX   PubMed=28458055; DOI=10.1016/j.sbi.2017.04.005;
RA   Engelman A.N., Cherepanov P.;
RT   "Retroviral intasomes arising.";
RL   Curr. Opin. Struct. Biol. 47:23-29(2017).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1332-1487.
RX   PubMed=7563093; DOI=10.1006/jmbi.1995.0556;
RA   Bujacz G., Jaskolski M., Alexandratos J., Wlodawer A., Merkel G.,
RA   Katz R.A., Skalka A.M.;
RT   "High-resolution structure of the catalytic domain of avian sarcoma virus
RT   integrase.";
RL   J. Mol. Biol. 253:333-346(1995).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1334-1477.
RX   PubMed=8805516; DOI=10.1016/s0969-2126(96)00012-3;
RA   Bujacz G., Jaskolski M., Alexandratos J., Wlodawer A., Merkel G.,
RA   Katz R.A., Skalka A.M.;
RT   "The catalytic domain of avian sarcoma virus integrase: conformation of the
RT   active-site residues in the presence of divalent cations.";
RL   Structure 4:89-96(1996).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1334-1479, ACTIVE SITE
RP   (INTEGRASE), AND FUNCTION (INTEGRASE).
RX   PubMed=9218451; DOI=10.1074/jbc.272.29.18161;
RA   Bujacz G., Alexandratos J., Wlodawer A., Merkel G., Andrake M., Katz R.A.,
RA   Skalka A.M.;
RT   "Binding of different divalent cations to the active site of avian sarcoma
RT   virus integrase and their effects on enzymatic activity.";
RL   J. Biol. Chem. 272:18161-18168(1997).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1332-1487 IN COMPLEX WITH A HIV-1
RP   INTEGRASE-TARGETED INHIBITOR.
RX   PubMed=9560188; DOI=10.1073/pnas.95.9.4831;
RA   Lubkowski J., Yang F., Alexandratos J., Wlodawer A., Zhao H.,
RA   Burke T.R. Jr., Neamati N., Pommier Y., Merkel G., Skalka A.M.;
RT   "Structure of the catalytic domain of avian sarcoma virus integrase with a
RT   bound HIV-1 integrase-targeted inhibitor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4831-4836(1998).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1334-1479, AND MUTAGENESIS OF
RP   ASP-1344.
RX   PubMed=9830010; DOI=10.1074/jbc.273.49.32685;
RA   Lubkowski J., Yang F., Alexandratos J., Merkel G., Katz R.A., Gravuer K.,
RA   Skalka A.M., Wlodawer A.;
RT   "Structural basis for inactivating mutations and pH-dependent activity of
RT   avian sarcoma virus integrase.";
RL   J. Biol. Chem. 273:32685-32689(1998).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.02 ANGSTROMS) OF 1333-1487.
RX   PubMed=10521258; DOI=10.1021/bi991362q;
RA   Lubkowski J., Dauter Z., Yang F., Alexandratos J., Merkel G., Skalka A.M.,
RA   Wlodawer A.;
RT   "Atomic resolution structures of the core domain of avian sarcoma virus
RT   integrase and its D64N mutant.";
RL   Biochemistry 38:13512-13522(1999).
CC   -!- FUNCTION: Capsid protein p27: Self-associates to form the irregular
CC       polyhedron core composed of hexamers and pentamers, that encapsulates
CC       the genomic RNA-nucleocapsid complex. Assembles as a tube in vitro.
CC       {ECO:0000250|UniProtKB:P03322}.
CC   -!- FUNCTION: Spacer peptide: Plays a role in the oligomerization of the
CC       Gag polyprotein and in the stabilization of the immature particle.
CC       Essential layering element during tube assembly.
CC       {ECO:0000250|UniProtKB:P03322}.
CC   -!- FUNCTION: [Nucleocapsid protein p12]: Binds strongly to viral nucleic
CC       acids and promote their aggregation. Also destabilizes the nucleic
CC       acids duplexes via highly structured zinc-binding motifs.
CC       {ECO:0000305}.
CC   -!- FUNCTION: [Protease p15]: The aspartyl protease mediates proteolytic
CC       cleavages of Gag and Gag-Pol polyproteins during or shortly after the
CC       release of the virion from the plasma membrane. Cleavages take place as
CC       an ordered, step-wise cascade to yield mature proteins. This process is
CC       called maturation. Displays maximal activity during the budding process
CC       just prior to particle release from the cell. {ECO:0000255|PROSITE-
CC       ProRule:PRU00275}.
CC   -!- FUNCTION: [Integrase]: Catalyzes viral DNA integration into the host
CC       chromosome, by performing a series of DNA cutting and joining reactions
CC       (PubMed:9218451). This recombination event is an essential step in the
CC       viral replication cycle. Has a strong preference for using the 3'-OH at
CC       the viral DNA end as a nucleophile. {ECO:0000250|UniProtKB:P03354,
CC       ECO:0000269|PubMed:9218451}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.49; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.; EC=3.1.26.4;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00408};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=The RT polymerase active site binds 2 magnesium ions.
CC       {ECO:0000255|PROSITE-ProRule:PRU00405};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium ions for ribonuclease H (RNase H) activity.
CC       Substrate-binding is a precondition for magnesium binding.
CC       {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P03354};
CC       Note=Binds 8 Mg(2+) ions per integrase homotetramer. {ECO:0000250};
CC   -!- SUBUNIT: [Protease p15]: Active as a homodimer.
CC       {ECO:0000250|UniProtKB:P03322}.
CC   -!- SUBUNIT: [Integrase]: Homodimer; further associates as a homooctamer.
CC       {ECO:0000250|UniProtKB:P03322, ECO:0000303|PubMed:28458055,
CC       ECO:0000303|PubMed:9218451}.
CC   -!- SUBUNIT: [Reverse transcriptase beta-subunit]: Heterodimer of alpha and
CC       beta subunits. Three forms of RT exist: alpha-alpha (alpha-Pol), beta-
CC       beta (beta-Pol), and alpha-beta, with the major form being the
CC       heterodimer. Both the polymerase and RNase H active sites are located
CC       in the alpha subunit of heterodimeric RT alpha-beta.
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- SUBUNIT: [Reverse transcriptase alpha-subunit]: Heterodimer of alpha
CC       and beta subunits. Three forms of RT exist: alpha-alpha (alpha-Pol),
CC       beta-beta (beta-Pol), and alpha-beta, with the major form being the
CC       heterodimer. Both the polymerase and RNase H active sites are located
CC       in the alpha subunit of heterodimeric RT alpha-beta.
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- SUBCELLULAR LOCATION: [Matrix protein p19]: Virion
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- SUBCELLULAR LOCATION: [Capsid protein p27, alternate cleaved 1]: Virion
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- SUBCELLULAR LOCATION: [Capsid protein p27, alternate cleaved 2]: Virion
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- SUBCELLULAR LOCATION: [Nucleocapsid protein p12]: Virion
CC       {ECO:0000250|UniProtKB:P03354}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Ribosomal frameshifting; Named isoforms=2;
CC         Comment=Translation results in the formation of the Gag polyprotein.
CC         Ribosomal frameshifting at the gag/pol genes boundary produces the
CC         Gag-Pol polyprotein.;
CC       Name=Gag-Pol polyprotein;
CC         IsoId=O92956-1; Sequence=Displayed;
CC       Name=Gag polyprotein;
CC         IsoId=O92954-1; Sequence=External;
CC   -!- DOMAIN: [Gag-Pol polyprotein]: Late-budding domains (L domains) are
CC       short sequence motifs essential for viral particle release. They can
CC       occur individually or in close proximity within structural proteins.
CC       They interacts with sorting cellular proteins of the multivesicular
CC       body (MVB) pathway. Most of these proteins are class E vacuolar protein
CC       sorting factors belonging to ESCRT-I, ESCRT-II or ESCRT-III complexes.
CC       P2B contains two L domain: a PPXY motif which probably binds to the WW
CC       domains of HECT (homologous to E6-AP C-terminus) E3 ubiquitin ligases
CC       and a LYPX(n)L domain which is known to bind the Alix adaptator
CC       protein. {ECO:0000250|UniProtKB:P03354}.
CC   -!- DOMAIN: [Integrase]: The core domain contains the D-x(n)-D-x(35)-E
CC       motif, named for the phylogenetically conserved glutamic acid and
CC       aspartic acid residues and the invariant 35 amino acid spacing between
CC       the second and third acidic residues. Each acidic residue of the
CC       D,D(35)E motif is independently essential for the 3'-processing and
CC       strand transfer activities of purified integrase protein (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: [Gag-Pol polyprotein]: Contains a nuclear export signal in p10
CC       and a nucleolar localization signal in nucleocapsid protein p12.
CC       {ECO:0000250|UniProtKB:P03322}.
CC   -!- DOMAIN: Capsid protein p27: Proton-driven dimerization of the C-
CC       terminus facilitates capsid assembly. {ECO:0000250|UniProtKB:P03322}.
CC   -!- PTM: [Isoform Gag-Pol polyprotein]: Specific enzymatic cleavages in
CC       vivo yield mature proteins. {ECO:0000250|UniProtKB:P03354}.
CC   -!- PTM: Capsid protein p27: The cleavage at the C-terminus is slowly
CC       trimmed by the viral protease, sometimes being cut internally thereby
CC       generating the short version of the capsid protein and a capsid protein
CC       C-terminally extended by 3 amino acids in a ratio of 2:1.
CC       {ECO:0000250|UniProtKB:P03322}.
CC   -!- MISCELLANEOUS: Reverse transcriptase: Error-prone enzyme that lacks a
CC       proof-reading function. High mutations rate is a direct consequence of
CC       this characteristic. RT also displays frequent template switching
CC       leading to high recombination rate. Recombination mostly occurs between
CC       homologous regions of the two copackaged RNA genomes. If these two RNA
CC       molecules derive from different viral strains, reverse transcription
CC       will give rise to highly recombinated proviral DNAs.
CC       {ECO:0000255|PROSITE-ProRule:PRU00405}.
CC   -!- MISCELLANEOUS: [Isoform Gag-Pol polyprotein]: Produced by -1 ribosomal
CC       frameshifting.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC08988.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF052428; AAC08988.1; ALT_INIT; Genomic_DNA.
DR   PDB; 1A5V; X-ray; 1.90 A; A=1332-1487.
DR   PDB; 1A5W; X-ray; 2.00 A; A=1332-1487.
DR   PDB; 1A5X; X-ray; 1.90 A; A=1332-1487.
DR   PDB; 1ASU; X-ray; 1.70 A; A=1332-1487.
DR   PDB; 1ASV; X-ray; 2.20 A; A=1332-1487.
DR   PDB; 1ASW; X-ray; 1.80 A; A=1332-1487.
DR   PDB; 1CXQ; X-ray; 1.02 A; A=1333-1487.
DR   PDB; 1CXU; X-ray; 1.42 A; A=1333-1487.
DR   PDB; 1CZ9; X-ray; 1.20 A; A=1333-1487.
DR   PDB; 1CZB; X-ray; 1.06 A; A=1333-1487.
DR   PDB; 1VSD; X-ray; 1.70 A; A=1335-1479.
DR   PDB; 1VSE; X-ray; 2.20 A; A=1335-1479.
DR   PDB; 1VSF; X-ray; 2.05 A; A=1335-1479.
DR   PDB; 1VSH; X-ray; 1.95 A; A=1335-1479.
DR   PDB; 1VSI; X-ray; 2.20 A; A=1335-1479.
DR   PDB; 1VSJ; X-ray; 2.10 A; A=1335-1479.
DR   PDB; 1VSK; X-ray; 2.20 A; A=1334-1479.
DR   PDB; 1VSL; X-ray; 2.20 A; A=1334-1479.
DR   PDB; 1VSM; X-ray; 2.15 A; A=1334-1479.
DR   PDB; 3O4N; X-ray; 1.80 A; A/B=1333-1479.
DR   PDB; 3O4Q; X-ray; 1.55 A; A=1333-1479.
DR   PDBsum; 1A5V; -.
DR   PDBsum; 1A5W; -.
DR   PDBsum; 1A5X; -.
DR   PDBsum; 1ASU; -.
DR   PDBsum; 1ASV; -.
DR   PDBsum; 1ASW; -.
DR   PDBsum; 1CXQ; -.
DR   PDBsum; 1CXU; -.
DR   PDBsum; 1CZ9; -.
DR   PDBsum; 1CZB; -.
DR   PDBsum; 1VSD; -.
DR   PDBsum; 1VSE; -.
DR   PDBsum; 1VSF; -.
DR   PDBsum; 1VSH; -.
DR   PDBsum; 1VSI; -.
DR   PDBsum; 1VSJ; -.
DR   PDBsum; 1VSK; -.
DR   PDBsum; 1VSL; -.
DR   PDBsum; 1VSM; -.
DR   PDBsum; 3O4N; -.
DR   PDBsum; 3O4Q; -.
DR   BMRB; O92956; -.
DR   SMR; O92956; -.
DR   EvolutionaryTrace; O92956; -.
DR   Proteomes; UP000159275; Genome.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044823; F:retroviral integrase activity; IDA:UniProtKB.
DR   GO; GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0015074; P:DNA integration; IEA:UniProtKB-KW.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0075713; P:establishment of integrated proviral latency; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:InterPro.
DR   GO; GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW.
DR   GO; GO:0044826; P:viral genome integration into host DNA; IEA:UniProtKB-KW.
DR   CDD; cd05482; HIV_retropepsin_like; 1.
DR   Gene3D; 1.10.10.200; -; 1.
DR   Gene3D; 1.10.1200.30; -; 1.
DR   Gene3D; 1.10.150.90; -; 1.
DR   Gene3D; 1.10.375.10; -; 1.
DR   Gene3D; 2.30.30.10; -; 1.
DR   Gene3D; 2.40.70.10; -; 1.
DR   Gene3D; 3.30.420.10; -; 2.
DR   Gene3D; 3.30.70.270; -; 2.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR004028; Gag_M.
DR   InterPro; IPR000721; Gag_p24_N.
DR   InterPro; IPR017856; Integrase-like_N.
DR   InterPro; IPR036862; Integrase_C_dom_sf_retrovir.
DR   InterPro; IPR001037; Integrase_C_retrovir.
DR   InterPro; IPR001584; Integrase_cat-core.
DR   InterPro; IPR003308; Integrase_Zn-bd_dom_N.
DR   InterPro; IPR012344; Matrix_HIV/RSV_N.
DR   InterPro; IPR001995; Peptidase_A2_cat.
DR   InterPro; IPR021109; Peptidase_aspartic_dom_sf.
DR   InterPro; IPR034170; Retropepsin-like_cat_dom.
DR   InterPro; IPR018061; Retropepsins.
DR   InterPro; IPR008916; Retrov_capsid_C.
DR   InterPro; IPR008919; Retrov_capsid_N.
DR   InterPro; IPR010999; Retrovr_matrix.
DR   InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR002156; RNaseH_domain.
DR   InterPro; IPR036397; RNaseH_sf.
DR   InterPro; IPR000477; RT_dom.
DR   InterPro; IPR010661; RVT_thumb.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00607; Gag_p24; 1.
DR   Pfam; PF00552; IN_DBD_C; 1.
DR   Pfam; PF02022; Integrase_Zn; 1.
DR   Pfam; PF02813; Retro_M; 1.
DR   Pfam; PF00665; rve; 1.
DR   Pfam; PF00077; RVP; 1.
DR   Pfam; PF00078; RVT_1; 1.
DR   Pfam; PF06817; RVT_thumb; 1.
DR   Pfam; PF00098; zf-CCHC; 1.
DR   SMART; SM00343; ZnF_C2HC; 2.
DR   SUPFAM; SSF46919; SSF46919; 1.
DR   SUPFAM; SSF47836; SSF47836; 1.
DR   SUPFAM; SSF47943; SSF47943; 1.
DR   SUPFAM; SSF50122; SSF50122; 1.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   SUPFAM; SSF53098; SSF53098; 2.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   SUPFAM; SSF57756; SSF57756; 1.
DR   PROSITE; PS50175; ASP_PROT_RETROV; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 1.
DR   PROSITE; PS50994; INTEGRASE; 1.
DR   PROSITE; PS51027; INTEGRASE_DBD; 1.
DR   PROSITE; PS50879; RNASE_H_1; 1.
DR   PROSITE; PS50878; RT_POL; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
DR   PROSITE; PS50876; ZF_INTEGRASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA integration; DNA recombination; DNA-binding;
KW   Endonuclease; Hydrolase; Magnesium; Metal-binding; Multifunctional enzyme;
KW   Nuclease; Nucleotidyltransferase; Ribosomal frameshifting;
KW   RNA-directed DNA polymerase; Transferase; Viral genome integration; Virion;
KW   Virus entry into host cell; Zinc; Zinc-finger.
FT   CHAIN           1..1603
FT                   /note="Gag-Pol polyprotein"
FT                   /id="PRO_0000442480"
FT   CHAIN           1..155
FT                   /note="Matrix protein p19"
FT                   /id="PRO_0000397058"
FT   CHAIN           156..166
FT                   /note="p2A"
FT                   /id="PRO_0000397059"
FT   CHAIN           167..177
FT                   /note="p2B"
FT                   /id="PRO_0000397060"
FT   CHAIN           178..239
FT                   /note="p10"
FT                   /id="PRO_0000397061"
FT   CHAIN           240..479
FT                   /note="Capsid protein p27, alternate cleaved 2"
FT                   /id="PRO_0000397062"
FT   CHAIN           240..476
FT                   /note="Capsid protein p27, alternate cleaved 1"
FT                   /id="PRO_0000442481"
FT   CHAIN           480..488
FT                   /note="p3"
FT                   /id="PRO_0000397063"
FT   CHAIN           489..577
FT                   /note="Nucleocapsid protein p12"
FT                   /id="PRO_0000397064"
FT   CHAIN           578..708
FT                   /note="Protease p15"
FT                   /id="PRO_0000397065"
FT   CHAIN           709..1567
FT                   /note="Reverse transcriptase beta-subunit"
FT                   /id="PRO_0000397066"
FT   CHAIN           709..1280
FT                   /note="Reverse transcriptase alpha-subunit"
FT                   /id="PRO_0000040984"
FT   CHAIN           1281..1567
FT                   /note="Integrase"
FT                   /id="PRO_0000040985"
FT   CHAIN           1568..1603
FT                   /note="p4"
FT                   /id="PRO_0000397067"
FT   DOMAIN          609..690
FT                   /note="Peptidase A2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00275"
FT   DOMAIN          750..938
FT                   /note="Reverse transcriptase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00405"
FT   DOMAIN          1149..1280
FT                   /note="RNase H type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00408"
FT   DOMAIN          1333..1496
FT                   /note="Integrase catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00457"
FT   ZN_FING         507..524
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         533..550
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         1280..1321
FT                   /note="Integrase-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00450"
FT   DNA_BIND        1502..1550
FT                   /note="Integrase-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00506"
FT   REGION          128..150
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          181..215
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          544..571
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1548..1567
FT                   /note="Involved in homooctamerization"
FT                   /evidence="ECO:0000250|UniProtKB:P03354"
FT   REGION          1549..1603
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           172..175
FT                   /note="PPXY motif"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   MOTIF           180..184
FT                   /note="LYPX(n)L motif"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   MOTIF           219..229
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   ACT_SITE        614
FT                   /note="For protease activity; shared with dimeric partner"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10094"
FT   BINDING         815
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic; for reverse transcriptase
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00405"
FT   BINDING         890
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic; for reverse transcriptase
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00405"
FT   BINDING         891
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic; for reverse transcriptase
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00405"
FT   BINDING         1158
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNase H activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00408"
FT   BINDING         1192
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNase H activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00408"
FT   BINDING         1213
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNase H activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00408"
FT   BINDING         1272
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic; for RNase H activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00408"
FT   BINDING         1289
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00450"
FT   BINDING         1293
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00450"
FT   BINDING         1317
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00450"
FT   BINDING         1320
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00450"
FT   BINDING         1344
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT                   /ligand_note="catalytic; for integrase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00457,
FT                   ECO:0000269|PubMed:9218451"
FT   BINDING         1401
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT                   /ligand_note="catalytic; for integrase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00457,
FT                   ECO:0000269|PubMed:9218451"
FT   BINDING         1437
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="3"
FT                   /ligand_note="catalytic; for integrase activity"
FT                   /evidence="ECO:0000250|UniProtKB:P03354,
FT                   ECO:0000269|PubMed:9218451"
FT   SITE            155..156
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            166..167
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            177..178
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            239..240
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            418
FT                   /note="Involved in capsid protein dimerization upon
FT                   acidification"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            430
FT                   /note="Involved in capsid protein dimerization upon
FT                   acidification"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            476..477
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            479..480
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            488..489
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            577..578
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03322"
FT   SITE            708..709
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03354"
FT   SITE            1280..1281
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250|UniProtKB:P03354"
FT   SITE            1567..1568
FT                   /note="Cleavage; by viral protease p15"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         1344
FT                   /note="D->N: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:9830010"
FT   CONFLICT        1376
FT                   /note="V -> A (in Ref. 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1441
FT                   /note="R -> K (in Ref. 4)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1331..1333
FT                   /evidence="ECO:0007829|PDB:1ASU"
FT   STRAND          1340..1347
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   HELIX           1349..1351
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1356..1362
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   TURN            1363..1365
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1368..1375
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   HELIX           1378..1392
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1396..1399
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   HELIX           1404..1407
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   HELIX           1409..1418
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1421..1423
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1428..1432
FT                   /evidence="ECO:0007829|PDB:1ASU"
FT   HELIX           1434..1453
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   STRAND          1457..1459
FT                   /evidence="ECO:0007829|PDB:1CXQ"
FT   HELIX           1462..1477
FT                   /evidence="ECO:0007829|PDB:1CXQ"
SQ   SEQUENCE   1603 AA;  173990 MW;  3BEFAA397C54CDE7 CRC64;
     MEAVIKVISS ACKTYCGKTS PSKKEIGAML SLLQKEGLLM SPSDLYSPGS WDPITAALSQ
     RAMVLGKSGE LKTWGLVLGA LKAAREEQVT SEQAKFWLGL GGGRVSPPGP ECIEKPATER
     RIDKGEEVGE TTVQRDAKMA PEETATPKTV GTSCYHCGTA IGCNCATASA PPPPYVGSGL
     YPSLAGVGEQ QGQGGDTPRG AEQPRAEPGH AGLAPGPALT DWARIREELA STGPPVVAMP
     VVIKTEGPAW TPLEPKLITR LADTVRTKGL RSPITMAEVE ALMSSPLLPH DVTNLMRVIL
     GPAPYALWMD AWGVQLQTVI AAATRDPRHP ANGQGRGERT NLDRLKGLAD GMVGNPQGQA
     ALLRPGELVA ITASALQAFR EVARLAEPAG PWADITQGPS ESFVDFANRL IKAVEGSDLP
     PSARAPVIID CFRQKSQPDI QQLIRAAPST LTTPGEIIKY VLDRQKIAPL TDQGIAAAMS
     SAIQPLVMAV VNRERDGQTG SGGRARRLCY TCGSPGHYQA QCPKKRKSGN SRERCQLCDG
     MGHNAKQCRR RDSNQGQRPG RGLSSGPWPV SEQPAVSLAM TMEHKDRPLV RVILTNTGSH
     PVKQRSVYIT ALLDSGADIT IISEEDWPTD WPVVDTANPQ IHGIGGGIPM RKSRDMIELG
     VINRDGSLER PLLLFPAVAM VRGSILGRDC LQGLGLRLTN LVGRATVLTV ALHLAIPLKW
     KPDHTPVWID QWPLPEGKLV ALTQLVEKEL QLGHIEPSLS CWNTPVFVIR KASGSYRLLH
     DLRAVNAKLV PFGAVQQGAP VLSALPRGWP LMVLDLKDCF FSIPLAEQDR EAFAFTLPSV
     NNQAPARRFQ WKVLPQGMTC SPTICQLVVG QVLEPLRLKH PSLRMLHYMD DLLLAASSHD
     GLEAAGEEVI NTLERAGFTI SPDKIQREPG VQYLGYKLGS TYVAPVGLVA EPRIATLWDV
     QKLVGSLQWL RPALGIPPRL MGPFYEQLRG SDPNEAREWN LDMKMAWREI VQLSTTAALE
     RWDPALPLEG AVVRCEQGAI GVLGQGLSTH PRPCLWLFST QPTKAFTAWL EVLTLLITKL
     RASAVRTFGK EVDILLLPAC FREDLPLPEG ILLALRGFAG KIRSSDTPSI FDIARPLHVS
     LKVRVTDHPV PGPTVFTDAS SSTHKGVVVW REGPRWEIKE IADLGASVQQ LEARAVAMAL
     LLWPTTPTNV VTDSAFVAKM LLKMGQEGVP STAAAFILED ALSQRSAMAA VLHVRSHSEV
     PGFFTEGNDV ADSQATFQAY PLREAKDLHT TLHIGPRALS KACNISMQQA REVVQTCPHC
     NSAPALEAGV NPRGLGPLQI WQTDFTLEPR MAPRSWLAVT VDTASSAIVV TQHGRVTSVA
     AQHHWATAIA VLGRPKAIKT DNGSCFTSKS TREWLARWGI AHTTGIPGNS QGQAMVERAN
     RLLKDKIRVL AEGDGFMKRI PASKQGELLA KAMYALNHFE RGENTKTPVQ KHWRPTVLTE
     GPPVKIRIET GEWEKGWNVL VWGRGYAAVK NRDTDKVIWV PSRKVKPDIT QKDEVTKKDE
     ASPLFAGSSD WIPWGDEQEG LQEEAASNKQ EGPGEDTLAA NES
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024